Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira to Present at the 16th Annual BIO CEO & Investor Conference Feb 05, 2014 Tekmira to Present at the 16th Annual BIO CEO & Investor Conference 11.7 KB ... Read more Summary ToggleTekmira Receives US$14.5 Million Milestone Payment Jan 21, 2014 Tekmira Receives US$14.5 Million Milestone Payment 14.9 KB ... Read more Summary ToggleTekmira Doses First Subject in Human Clinical Trial of TKM-Ebola Jan 14, 2014 Tekmira Doses First Subject in Human Clinical Trial of TKM-Ebola 19.7 KB ... Read more Summary ToggleTekmira Signs Development Agreement on Delivery Technology for Agricultural Applications Jan 13, 2014 Tekmira Signs Development Agreement on Delivery Technology for Agricultural Applications 19 KB ... Read more Summary ToggleTekmira Announces Strategic Reorganization to Strengthen Leadership Team Jan 06, 2014 Tekmira Announces Strategic Reorganization to Strengthen Leadership Team 19.3 KB ... Read more Summary ToggleTekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02) Dec 16, 2013 Tekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02) 18.2 KB ... Read more Summary ToggleTekmira's Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation Dec 13, 2013 Tekmira's Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation 20.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Third Quarter 2013 Results Nov 13, 2013 Tekmira Provides Corporate Update and Announces Third Quarter 2013 Results 27.3 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Announces New Preclinical Data from Anti-Viral Programs Nov 12, 2013 Tekmira Announces New Preclinical Data from Anti-Viral Programs 22.9 KB ... Read more Summary ToggleTekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02) Nov 10, 2013 Tekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02) 18.5 KB Phase II Data Presented at Scientific Symposium Further Validates Tekmira's LNP Technology ... Read more Pagination First page First Previous page Previous … Page 30 Current page 31 Page 32 Page 33 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira to Present at the 16th Annual BIO CEO & Investor Conference Feb 05, 2014 Tekmira to Present at the 16th Annual BIO CEO & Investor Conference 11.7 KB ... Read more Summary ToggleTekmira Receives US$14.5 Million Milestone Payment Jan 21, 2014 Tekmira Receives US$14.5 Million Milestone Payment 14.9 KB ... Read more Summary ToggleTekmira Doses First Subject in Human Clinical Trial of TKM-Ebola Jan 14, 2014 Tekmira Doses First Subject in Human Clinical Trial of TKM-Ebola 19.7 KB ... Read more Summary ToggleTekmira Signs Development Agreement on Delivery Technology for Agricultural Applications Jan 13, 2014 Tekmira Signs Development Agreement on Delivery Technology for Agricultural Applications 19 KB ... Read more Summary ToggleTekmira Announces Strategic Reorganization to Strengthen Leadership Team Jan 06, 2014 Tekmira Announces Strategic Reorganization to Strengthen Leadership Team 19.3 KB ... Read more Summary ToggleTekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02) Dec 16, 2013 Tekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02) 18.2 KB ... Read more Summary ToggleTekmira's Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation Dec 13, 2013 Tekmira's Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation 20.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Third Quarter 2013 Results Nov 13, 2013 Tekmira Provides Corporate Update and Announces Third Quarter 2013 Results 27.3 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Announces New Preclinical Data from Anti-Viral Programs Nov 12, 2013 Tekmira Announces New Preclinical Data from Anti-Viral Programs 22.9 KB ... Read more Summary ToggleTekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02) Nov 10, 2013 Tekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02) 18.5 KB Phase II Data Presented at Scientific Symposium Further Validates Tekmira's LNP Technology ... Read more Pagination First page First Previous page Previous … Page 30 Current page 31 Page 32 Page 33 … Next page Next Last page Last
Tekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02) 18.2 KB